Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Drugs of Today (Barcelona, Spain : 1998)|October 29, 2021
Evinacumab to treat hypercholesterolemiaC Engler, C EbenbichlerAIDS (London, England)|January 1, 1995
Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1H Stoiber, C Ebenbichler, R Schneider, et al.AIDS (London, England)|May 1, 1993
Structure-function relationships of the HIV-1 envelope V3 loop tropism determinant: evidence for two distinct conformationsC Ebenbichler, P Westervelt, A Carrillo, et al.European Journal of Immunology|February 1, 1994
The envelope glycoprotein of HIV-1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenic homologyH Stoiber, N M Thielens, C Ebenbichler, et al.Wiener Klinische Wochenschrift|April 11, 2001
Analysis of volatile organic compounds: possible applications in metabolic disorders and cancer screeningJ Rieder, P Lirk, C Ebenbichler, et al.Infection and Immunity|April 1, 1993
Isolation and biochemical characterization of the iC3b receptor of Candida albicansS Alaei, C Larcher, C Ebenbichler, et al.Biology of Sport|June 9, 2016
Acute effects of concentric and eccentric exercise on glucose metabolism and interleukin-6 concentration in healthy malesM Philippe, P J Krüsmann, L Mersa, et al.The American Journal of Psychiatry|October 2, 2001
Association of olanzapine-induced weight gain with an increase in body fatU Eder, B Mangweth, C Ebenbichler, et al.Cardiovascular Research|December 12, 2001
Pronounced postprandial lipemia impairs endothelium-dependent dilation of the brachial artery in menH Gaenzer, W Sturm, G Neumayr, et al.AIDS (London, England)|June 1, 1992
HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9Y H Chen, C Ebenbichler, R Vornhagen, et al.Pageof 2